Literature DB >> 2811620

Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.

E C Unger1, P MacDougall, P Cullis, C Tilcock.   

Abstract

Liposomes entrapping gadolinium-DTPA (Gd-DTPA) were synthesized from 60 mole percent egg phosphatidylcholine (EPC) and 40 mole percent cholesterol or EPC alone entrapping Gd-DTPA in diameters of 100 and 200 nm. Rats bearing Morris hepatoma in their flanks were imaged by MR pre- and post-contrast with free Gd-DTPA and liposomal Gd-DTPA for up to four hours after IV contrast. Comparison of images after free and liposomal Gd-DTPA showed dramatic differences in tumor and organ enhancement. Liposomal Gd-DTPA enhancement of tumor corresponded more closely to histologically proven vascularized portions of tumor than free Gd-DTPA. Hepatic enhancement was greater with liposomal than free Gd-DTPA and time course of liver, kidney and tumor enhancement was prolonged. The 100-nm EPC Gd-DTPA liposomes caused the greatest enhancement. Gd-DTPA liposomes may be useful as liver and blood pool contrast agents. By varying lipid composition and vesicle size, patterns of enhancement may be selectively modified.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2811620     DOI: 10.1016/0730-725x(89)90491-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  9 in total

Review 1.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

2.  MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.

Authors:  Xiaoli Liu; Achuthamangalam B Madhankumar; Patti A Miller; Kari A Duck; Susan Hafenstein; Elias Rizk; Becky Slagle-Webb; Jonas M Sheehan; James R Connor; Qing X Yang
Journal:  Neuro Oncol       Date:  2015-10-31       Impact factor: 12.300

3.  Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.

Authors:  Wenbin Lin; Taeghwan Hyeon; Gregory M Lanza; Miqin Zhang; Thomas J Meade
Journal:  MRS Bull       Date:  2009-06       Impact factor: 6.578

4.  Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.

Authors:  Zhiliang Cheng; Daniel L J Thorek; Andrew Tsourkas
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

Review 5.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

6.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

Authors:  R Gref; A Domb; P Quellec; T Blunk; R H Müller; J M Verbavatz; R Langer
Journal:  Adv Drug Deliv Rev       Date:  1995-09       Impact factor: 15.470

7.  Molecular platform for design and synthesis of targeted dual-modality imaging probes.

Authors:  Amit Kumar; Shanrong Zhang; Guiyang Hao; Gedaa Hassan; Saleh Ramezani; Koji Sagiyama; Su-Tang Lo; Masaya Takahashi; A Dean Sherry; Orhan K Öz; Zoltan Kovacs; Xiankai Sun
Journal:  Bioconjug Chem       Date:  2015-02-20       Impact factor: 4.774

Review 8.  Progress on the diagnosis and evaluation of brain tumors.

Authors:  Huile Gao; Xinguo Jiang
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

Review 9.  Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents.

Authors:  Joan Estelrich; María Jesús Sánchez-Martín; Maria Antònia Busquets
Journal:  Int J Nanomedicine       Date:  2015-03-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.